Non-Opiod Pain Management With BUZZY

In this health supplier segment, pediatric emergency physician and pain specialist, Dr. Amy Baxter discusses the barriers to effective non-opioid pain management.  She has given up her practice to focus on devices she has invented to block out pain. She also talks about The Buzzy, which helps block needle pain for children. She is passionate about changing the pain treatment paradigm to include proven technologies like hers – and other non-pharma modalities – for the benefit of physicians, patient, and society as a whole.

Read More

Multiple Sclerosis Is On My Mind Initiative

Artist and patient Lydia Emily Archibald who is a spokesperson and creative director for MS On My Mind, an interactive initiative launched by EMD Serono, discusses her role in the project. She is joined by Dr. Daniel Bandari, M.D., M.S. founder of the Multiple Sclerosis Center of California, who discusses the physical challenges and prevalence associated with MS.

Read More

Microvillus Inclusion Disease (MVID)

Dr. Dmitry Kravtsov, M.D., Vice President of Research & Development at Vanessa Research, Inc. (VRI), discusses the white paper “Addressing the Microvillus Inclusion Disease Knowledge Gap – A Comprehensive Case Analysis”.  MVID is a rare genetic disease that afflicts infants with very severe diarrhea. Shylicine™ is the first-ever drug developed to treat microvillus inclusion disease.  

Read More

Adhansia XR™ For ADHD

Andrew J. Cutler, MD, chief medical officer, Meridien Research, and an investigator on Adhansia XR™ (methylphenidate HCI) clinical studies, discusses the new FDA approval of Adlon Therapeutics Adhansia XR™ extended-release capsules Cll for the treatment of Attention-Deficit/Hyperactivity Disorder in patients 6 and older.  

Read More